Body Pharm
Research explainer

What is Semaglutide?

Research use only. The summary below reflects reports in research literature. It is not medical advice or instructions for human use. Semaglutide is sold strictly for research and analytical purposes.

In Deutschland? See Semaglutide on our EU store on Body Pharm Deutschland, with German delivery.

In Czechia? See Semaglutide on our EU store on Body Pharm Česko, with delivery within Czechia.

In Spain? See Semaglutide on our EU store on Body Pharm España, with delivery within Spain.

What is Semaglutide?

Semaglutide is a GLP-1 receptor agonist peptide — the original single-receptor incretin — supplied for research as a pre-filled multi-dose pen.

It is the most established GLP-1 peptide in weight-loss and metabolic research, and the benchmark the dual- and triple-agonists are measured against. Research outcomes vary with dose and duration.

Reported side effects

  • Nausea and reduced appetite — the most commonly reported effects, usually easing with slow titration.
  • Other gastrointestinal effects at higher doses.
  • Mild, transient injection-site reactions.

How to dose Semaglutide

Dosed once weekly and titrated gradually — a conservative research ramp is 0.25 → 0.5 → 1 → up to 2 mg, stepping up every four weeks. The pen dials each dose.

Read the full Semaglutide dosing protocol

How to get Semaglutide

The Body Pharm Semaglutide pen is a sealed, HPLC-tested device with a published Certificate of Analysis. It is currently on the waitlist — reserve it to be first in line. Sold for research use only.

Cost per month

Confirmed on release — reserve free on the waitlist, no payment taken.

How to dose SemaglutideBest Peptides for Weight Loss
ByThe Body Pharm Research Team· Updated 12 July 2026

All Body Pharm products are sold strictly for research and analytical purposes only. Not for human consumption.